Benign bone tumour surgery

The clinical use of BonAlive® granules in benign bone tumour surgery is specifically supported by a long-term randomised prospective trial. The results clearly showed that the long-term performance of BonAlive® granules is comparable to autograft. The clinical trial extended up to 14-year follow-up in benign bone tumour surgery.

BonAlive® granules produces a high but balanced local bone turnover by stimulating new bone formation through osteostimulation*. The proven performance of BonAlive® granules shows that it is a well-tolerated and safe bone graft substitute, also in paediatric patients.

(*non-osteoinduction)

BonAlive® granules indications

  • Bone cavity filling
  • Bone cavity filling in the treatment of chronic osteomyelitis

BonAlive® putty indication

  • Bony voids and gaps

For further details see references.

BonAlive® granules
clinical cases orthopaedic
and trauma brochure

Bone formation